Damage-inducible intragenic demethylation of the humanTP53tumor suppressor gene is associated with transcription from an alternative intronic promoter
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Damage-inducible intragenic demethylation of the humanTP53tumor suppressor gene is associated with transcription from an alternative intronic promoter
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume 55, Issue 12, Pages 1940-1951
Publisher
Wiley
Online
2015-12-17
DOI
10.1002/mc.22441
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- On the presence and role of human gene-body DNA methylation
- (2015) Daudi Jjingo et al. Oncotarget
- Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer
- (2013) Marta Kulis et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition
- (2013) Alika K Maunakea et al. CELL RESEARCH
- Intragenic DNA methylation status down-regulates bovine IGF2 gene expression in different developmental stages
- (2013) Yong-Zhen Huang et al. GENE
- Molecular and Functional Evidence of HCN4 and Caveolin-3 Interaction During Cardiomyocyte Differentiation from Human Embryonic Stem Cells
- (2013) Alexis Bosman et al. STEM CELLS AND DEVELOPMENT
- The Unpluggable in Pursuit of the Undruggable: Tackling the Dark Matter of the Cancer Therapeutics Universe
- (2013) Richard J. Epstein Frontiers in Oncology
- Intragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk
- (2012) K. Brennan et al. CANCER RESEARCH
- Mutant p53: one name, many proteins
- (2012) W. A. Freed-Pastor et al. GENES & DEVELOPMENT
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- MicroRNAs, wild-type and mutant p53: More questions than answers
- (2012) Matthew Fletcher Jones et al. RNA Biology
- Hyperproliferation, cancer, and inflammation in mice expressing a 133p53-like isoform
- (2011) T. L. Slatter et al. BLOOD
- Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research
- (2011) N Shenker et al. BRITISH JOURNAL OF CANCER
- Diverse p63 and p73 isoforms regulate Δ133p53 expression through modulation of the internal TP53 promoter activity
- (2011) V Marcel et al. CELL DEATH AND DIFFERENTIATION
- RAD6 Regulates the Dosage of p53 by a Combination of Transcriptional and Posttranscriptional Mechanisms
- (2011) S. Chen et al. MOLECULAR AND CELLULAR BIOLOGY
- Regulation of the p14ARF promoter by DNA methylation
- (2010) Vinay Badal et al. CELL CYCLE
- p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage
- (2010) M Aoubala et al. CELL DEATH AND DIFFERENTIATION
- Δ160p53 is a novel N-terminal p53 isoform encoded by Δ133p53 transcript
- (2010) Virginie Marcel et al. FEBS LETTERS
- Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations
- (2010) Zeinab Barekati et al. HUMAN MOLECULAR GENETICS
- Exogenous nucleosides modulate expression and activity of transcription factors in Caco-2 cells
- (2010) Ángeles Ortega et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- DNA Methylation Increases Nucleosome Compaction and Rigidity
- (2010) John S. Choy et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Unveiling the methylation status of CpG dinucleotides in the substituted segment of the human p53 knock-in (Hupki) mouse genome
- (2010) Sang-In Kim et al. MOLECULAR CARCINOGENESIS
- Conserved role of intragenic DNA methylation in regulating alternative promoters
- (2010) Alika K. Maunakea et al. NATURE
- The impact of intragenic CpG content on gene expression
- (2010) Asli Petra Bauer et al. NUCLEIC ACIDS RESEARCH
- p53 regulates the transcription of its Δ133p53 isoform through specific response elements contained within the TP53 P2 internal promoter
- (2010) V Marcel et al. ONCOGENE
- Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer
- (2010) G Hofstetter et al. ONCOGENE
- p53 Research: The Past Thirty Years and the Next Thirty Years
- (2010) D. Lane et al. Cold Spring Harbor Perspectives in Biology
- p53 isoform 113p53 is a p53 target gene that antagonizes p53 apoptotic activity via BclxL activation in zebrafish
- (2009) J. Chen et al. GENES & DEVELOPMENT
- Wrap53, a Natural p53 Antisense Transcript Required for p53 Induction upon DNA Damage
- (2009) Salah Mahmoudi et al. MOLECULAR CELL
- p53 isoforms Δ133p53 and p53β are endogenous regulators of replicative cellular senescence
- (2009) Kaori Fujita et al. NATURE CELL BIOLOGY
- Small Molecular Weight Variants of p53 Are Expressed in Human Melanoma Cells and Are Induced by the DNA-Damaging Agent Cisplatin
- (2008) K. A. Avery-Kiejda et al. CLINICAL CANCER RESEARCH
- A human endothelial cell feeder system that efficiently supports the undifferentiated growth of mouse embryonic stem cells
- (2008) Haisheng Zhou et al. DIFFERENTIATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now